NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
10/29/2024
Back to search
Official data from USPTO
OSE-CYTOMASK
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
16
Latest update
10/29/2024
Trademark type
Word
Nice classes
5
Filing date
07/24/2023
Registration date
10/29/2024
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
10/29/2024
Last transaction
10/29/2024
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Foreign priority
Drawing code
4
Owner type
11
Owner location
Nantes, FR
Examiner
KHOURI, SANI
Current location
FILE REPOSITORY (FRANCONIA)
Holders and representatives
Holders
O. I. (pessoa física)
Representatives
Mary Grieco Lee Olshan Frome Wolosky LLP
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceuticals for the treatment of cancer and autoimmune diseases; Sanitary preparations for medical purposes; Dietetic foods and beverages adapted for medical use; Medicines for human purposesmedicines for treating cancer and autoimmune diseases; Chemical preparations for medical or pharmaceutical purposestreating cancer and autoimmune diseases; Vaccines; medicated serums for the treatment of cancer and autoimmune diseases; Chemical reagents for medical use; Disinfectants; Pharmaceutical preparations for the treatment of autoimmune diseases; Immunostimulants; Immunomodulators; Immunoassay reagents for medical use; Biological preparations for the treatment of cancer; Biological preparations for the treatment of cancer and autoimmune diseases; Monoclonal antibodies for use in disease testing
Publications
History of USPTO decisions and trademark events.
16 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
10/29/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
08/13/2024
PUBO
PUBLISHED FOR OPPOSITION
08/13/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
07/24/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
07/08/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
07/08/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
07/08/2024
ALIE
ASSIGNED TO LIE
07/08/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
01/12/2024
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
11/28/2023
GNRT
NON-FINAL ACTION E-MAILED
11/28/2023
CNRT
NON-FINAL ACTION WRITTEN
11/28/2023
DOCK
ASSIGNED TO EXAMINER
11/26/2023
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
08/22/2023
NWAP
NEW APPLICATION ENTERED
07/27/2023
Continuous trademark protection
Get notified about every new filing that threatens OSE-CYTOMASK or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.